FENNEC PHARMACEUTICALS INC. Quarterly Current Ratio in % from Q2 2019 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Fennec Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q2 2019 to Q2 2024.
Fennec Pharmaceuticals Inc. Current Ratio for the quarter ending June 30, 2024 was 610 %, a 4.49% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	610	-28.7	-4.49%	Jun 30, 2024
Q1 2024	535	-110	-17%	Mar 31, 2024
Q4 2023	456	-265	-36.8%	Dec 31, 2023
Q3 2023	537	-357	-40%	Sep 30, 2023
Q2 2023	638			Jun 30, 2023
Q1 2023	645			Mar 31, 2023
Q4 2022	720			Dec 31, 2022
Q3 2022	894			Sep 30, 2022
Q2 2021	1.35K	+404	+42.5%	Jun 30, 2021
Q1 2021	1.17K	+280	+31.6%	Mar 31, 2021
Q4 2020	1.11K	-18.2	-1.62%	Dec 31, 2020
Q3 2020	946	-484	-33.9%	Sep 30, 2020
Q2 2020	949	-367	-27.9%	Jun 30, 2020
Q1 2020	888			Mar 31, 2020
Q4 2019	1.13K			Dec 31, 2019
Q3 2019	1.43K			Sep 30, 2019
Q2 2019	1.32K			Jun 30, 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.